⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8806821 | 1.00 | — | — | |
| SCHEMBL8317048 | 1.00 | — | — | |
| SCHEMBL8806439 | 1.00 | — | — | |
| SCHEMBL17683594 | 0.76 | — | — | |
| SCHEMBL7868218 | 0.74 | — | — | |
| SCHEMBL8874188 | 0.74 | — | — | |
| SCHEMBL13051904 | 0.74 | — | — | |
| SCHEMBL12996745 | 0.74 | PPM1B (0.35) | — | |
| SCHEMBL27869449 | 0.71 | — | — | |
| SCHEMBL6313676 | 0.70 | PPM1B (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110467608-B | Synthetic method of emtricitabine | 武汉工程大学 | 2023-04-07 | — | — | CN | claimed |
| CN-102911167-A | Method for preparing nucleoside intermediate with high optical purity | UNIV HEFEI TECHNOLOGY | 2013-02-06 | — | — | CN | claimed |
| CN-102234269-A | Industrial preparation method for lamivudine | CHONGQING PHARM RES INST CO | 2011-11-09 | — | — | CN | claimed |
| CN-1274686-C | Suitable industrialized method of preparing Lamivudine | JIUCHUANG CHEMICAL CO LTD JINA (CN) | 2006-09-13 | — | — | CN | claimed |
| CN-1563003-A | Suitable industrialized method of preparing Lamivudine | JIUCHUANG CHEMICAL CO LTD JINA (CN) | 2005-01-12 | — | — | CN | claimed |
| CN-1563002-A | Suitqable to industrialized method for preparing emtricitabine | JIUCHUANG CHEMICAL CO LTD JINA (CN) | 2005-01-12 | — | — | CN | claimed |
| US-5693787-A | Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analogues | BIOCHEM PHARMA INC. (CA) | 1997-12-02 | — | — | US | claimed |
| EP-0515157-B1 | Processes for the diastereoselective synthesis of nucleosides | IAF BIOCHEM INT (CA) | 1997-09-03 | — | — | EP | claimed |
| WO-1992020669-A1 | PROCESSES FOR THE DIASTEREOSELECTIVE SYNTHESIS OF NUCLEOSIDES | BIOCHEM PHARMA INC. (CA) | 1992-11-26 | — | — | WO | claimed |
| EP-0515157-A1 | Processes for the diastereoselective synthesis of nucleosides | BIOCHEM PHARMA INC. (CA) | 1992-11-25 | — | — | EP | claimed |
| EP-3695837-B1 | A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR FOR TREATING HEPATITIS B | HOFFMANN LA ROCHE (CH) | 2024-11-20 | — | — | EP | disclosed |
| US-11771699-B2 | Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor | HOFFMANN-LA ROCHE INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771699-B2 | Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor | HOFFMANN-LA ROCHE INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771699-B2 | Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor | HOFFMANN-LA ROCHE INC. (US) | 2023-10-03 | — | — | US | disclosed |
| CN-116199679-A | Industrial preparation method of lamivudine | 吉斯凯(苏州)制药有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-5693787-A | Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analogues | BIOCHEM PHARMA INC. (CA) | 1997-12-02 | — | — | US | disclosed |
| EP-0515157-B1 | Processes for the diastereoselective synthesis of nucleosides | IAF BIOCHEM INT (CA) | 1997-09-03 | — | — | EP | disclosed |
| US-5663320-A | Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates | BIOCHEM PHARMA, INC. (CA) | 1997-09-02 | — | — | US | disclosed |
| WO-1992020669-A1 | PROCESSES FOR THE DIASTEREOSELECTIVE SYNTHESIS OF NUCLEOSIDES | BIOCHEM PHARMA INC. (CA) | 1992-11-26 | — | — | WO | disclosed |
| EP-0515157-A1 | Processes for the diastereoselective synthesis of nucleosides | BIOCHEM PHARMA INC. (CA) | 1992-11-25 | — | — | EP | disclosed |